3/3
07:00 am
imcr
Immunocore to present at upcoming investor conferences
Low
Report
Immunocore to present at upcoming investor conferences
3/1
11:32 am
imcr
Is It Time To Revisit Immunocore Holdings (IMCR) After Recent Pipeline Progress? [Yahoo! Finance]
Low
Report
Is It Time To Revisit Immunocore Holdings (IMCR) After Recent Pipeline Progress? [Yahoo! Finance]
2/27
06:26 am
imcr
Immunocore (IMCR) was downgraded by Zacks Research from "strong-buy" to "hold".
Low
Report
Immunocore (IMCR) was downgraded by Zacks Research from "strong-buy" to "hold".
2/26
08:03 am
imcr
Immunocore (IMCR) had its price target raised by Needham & Company LLC from $71.00 to $75.00. They now have a "buy" rating on the stock.
Low
Report
Immunocore (IMCR) had its price target raised by Needham & Company LLC from $71.00 to $75.00. They now have a "buy" rating on the stock.
2/25
02:36 pm
imcr
Immunocore Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Immunocore Q4 Earnings Call Highlights [Yahoo! Finance]
2/25
02:18 pm
imcr
Immunocore Holdings PLC (IMCR) Q4 2025 Earnings Call Highlights: Robust Revenue Growth and ... [Yahoo! Finance]
Low
Report
Immunocore Holdings PLC (IMCR) Q4 2025 Earnings Call Highlights: Robust Revenue Growth and ... [Yahoo! Finance]
2/25
02:06 pm
imcr
Immunocore Holdings plc (IMCR) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Immunocore Holdings plc (IMCR) Q4 2025 Earnings Call Transcript [Seeking Alpha]
2/25
07:18 am
imcr
Immunocore reports fourth quarter and full year 2025 financial results and provides a business update [Yahoo! Finance]
Low
Report
Immunocore reports fourth quarter and full year 2025 financial results and provides a business update [Yahoo! Finance]
2/25
07:00 am
imcr
Immunocore reports fourth quarter and full year 2025 financial results and provides a business update
Medium
Report
Immunocore reports fourth quarter and full year 2025 financial results and provides a business update
2/19
09:16 am
imcr
Immunocore (NASDAQ:IMCR) was given a new $38.00 price target on by analysts at Mizuho.
Low
Report
Immunocore (NASDAQ:IMCR) was given a new $38.00 price target on by analysts at Mizuho.
2/18
07:30 am
imcr
Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025 [Yahoo! Finance]
Low
Report
Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025 [Yahoo! Finance]
2/18
07:00 am
imcr
Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025
Low
Report
Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025
2/5
07:08 am
imcr
VectorY Therapeutics Appoints Kevin Pojasek, Ph.D., to Board of Directors
Low
Report
VectorY Therapeutics Appoints Kevin Pojasek, Ph.D., to Board of Directors
2/4
08:43 am
imcr
Immunocore (NASDAQ:IMCR) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
Low
Report
Immunocore (NASDAQ:IMCR) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
2/4
04:52 am
imcr
Levicept Announces the Appointment of James Sandy as Chief Development Officer [Yahoo! Finance]
Low
Report
Levicept Announces the Appointment of James Sandy as Chief Development Officer [Yahoo! Finance]
2/4
04:00 am
imcr
Levicept Announces the Appointment of James Sandy as Chief Development Officer
Low
Report
Levicept Announces the Appointment of James Sandy as Chief Development Officer
2/2
04:52 am
imcr
Assessing Immunocore Holdings (IMCR) Valuation After Recent Share Price Volatility [Yahoo! Finance]
Low
Report
Assessing Immunocore Holdings (IMCR) Valuation After Recent Share Price Volatility [Yahoo! Finance]
2/1
07:53 am
imcr
Moderna Refocuses On Rare Diseases As New Leadership Shapes Pipeline [Yahoo! Finance]
Low
Report
Moderna Refocuses On Rare Diseases As New Leadership Shapes Pipeline [Yahoo! Finance]
1/31
01:33 am
imcr
Low
Report
1/30
09:21 am
imcr
Moderna CMO Jacqueline Miller to step down [Yahoo! Finance]
Low
Report
Moderna CMO Jacqueline Miller to step down [Yahoo! Finance]
1/30
07:00 am
imcr
Immunocore announces R&D leadership evolution
Low
Report
Immunocore announces R&D leadership evolution
1/24
05:08 am
imcr
Immunocore (NASDAQ:IMCR) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Immunocore (NASDAQ:IMCR) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
1/19
11:45 am
imcr
JPM26: Immunocore Signals Entry into Type 1 Diabetes [Yahoo! Finance]
Low
Report
JPM26: Immunocore Signals Entry into Type 1 Diabetes [Yahoo! Finance]
1/10
10:56 am
imcr
How The Narrative Around Immunocore Holdings (IMCR) Is Shifting With New Data And Street Targets [Yahoo! Finance]
Low
Report
How The Narrative Around Immunocore Holdings (IMCR) Is Shifting With New Data And Street Targets [Yahoo! Finance]
1/9
07:41 am
imcr
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]